【Company Recommendation】Shaanxi Cuikang Pharmaceutical Technology Co., Ltd

October 13, 2025  Source: drugdu 84

"/

Company Introduction

Shaanxi Cuikang Pharmaceutical Technology Co., Ltd. is an enterprise integrating the research and development, production, sales and technical services of natural products, fine chemicals, biological fermentation and innovative materials. The company has built a 2,700-square-meter R&D center and two production lines (enzyme preparation production line + fine chemical production line) in Hanzhong, Shaanxi Province. We can provide global customers with proportionate plant extracts, content plant extracts, synthetic chemical building blocks, synthetic pharmaceutical intermediates, active API molecules, fermentation pharmaceutical intermediates and raw materials for active pharmaceutical products, health foods, functional foods, veterinary drug raw materials, innovative pharmaceutical materials, and laboratory equipment. One-stop services and products for pharmaceutical machinery and equipment series, ranging from small-scale trial research and development to industrial-scale production.

"/

The company conducts over 50 R&D and technical service projects annually, applies for more than 10 patents, and many of its scientific research achievements have now been industrially transformed in several pharmaceutical enterprises. The company closely follows the global development trends of the biopharmaceutical industry, leverages its technological and resource advantages, and delves deeply into the field of pharmaceutical intelligent manufacturing. It has established in-depth cooperative relationships with many well-known domestic pharmaceutical enterprises, research institutes, and CRO and CMO companies. Strive to build itself into a well-known domestic pharmaceutical research and development and manufacturing enterprise with considerable influence in the future.

"/

Overview of the Company's Key Competitive Products

39262-14-1 Ginsenoside CK:

As the leading manufacturer of ginsenoside series in Shaanxi Province, we are committed to excellence, leverage our competitive advantages to manage material costs effectively, and ensure product quality through advanced production technologies.

"/

989-51-5 (-)-Epigallocatechin gallate:

EGCG exhibits potent antioxidant properties and offers significant benefits for anti-inflammation, weight management, cardiovascular health, and cognitive function. It is extensively utilized in the fields of medicine, healthcare, the food industry, and cosmetics.

"/

906421-01-0 SLX-2101:

SLX-2101 is a highly selective, orally active, potent phosphodiesterase 5 (PDE5) inhibitor that can be used to study erectile dysfunction.

"/

611-59-6 1,7-DIMETHYLXANTHINE:

Paraxanthine is the most desirable of the three metabolites. As an adenosine antagonist, it acts similarly to caffeine, but is more potent, less toxic, and has fewer side effects than caffeine itself. Paraxanthine is a natural plant compound found in the stamens of coffee, cacao fruit, vines and citrus flowers. It is also a major metabolite of caffeine.

"/

23110-15-8 Fumagillin:

Fumagillin and its derivatives may play a potential role in the treatment of obesity, rheumatoid arthritis and other diseases.  In addition, it can also be used to control bee microsporidiosis, especially in the beekeeping and fish farming industry has an important role.With stable output, high quality and good price, the products have been favored by domestic and foreign customers.

"/

6019-06-3 Nicotine Ditartrate Dihydrate:

Pharmaceutical chemical raw materials. In the pharmaceutical field, it is used for nicotine replacement therapy. It helps smokers gradually reduce their dependence on cigarettes by providing a controlled dose of nicotine. This can relieve withdrawal symptoms such as cravings, irritability, and restlessness.

"/

Please visit our website: www.cuikangpha.com for more information.

By editor
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.